This inventor holds 1 USPTO granted patent. Top assignee: Oscobal Ag. Active years: 1986.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1986
Title: The Innovative Contributions of Frank Baumgart
Introduction
Frank Baumgart is a notable inventor based in Grenchen, Switzerland. He has made significant strides in the field of biomedical engineering, particularly in the development of bone substitute materials. His innovative approach combines collagen and hydroxyapatite to create a material that promotes the growth of natural bone tissue.
Latest Patents
Baumgart holds a patent for a method of producing a bone substitute material. This method involves mixing an aqueous solution of cleaned collagen with a cross-linking agent, which causes only partial cross-linking. The mixture is then lyophilized to create a material that retains its resorbability and absorptivity with respect to bodily fluids. The patent specifies that less than 1% by weight of formaldehyde is used as a cross-linking agent, ensuring that the material is both strong and less tearable than previously known alternatives. This innovative bone substitute material effectively promotes the growth of the body’s own bone tissue.
Career Highlights
Frank Baumgart is currently associated with Oscobal AG, where he continues to work on advancements in biomedical materials. His expertise in the field has led to the development of products that enhance patient outcomes in orthopedic applications. His dedication to research and innovation has positioned him as a key figure in his industry.
Collaborations
Baumgart collaborates with several professionals in his field, including Peter Ries and Heinz Mittelmeier. These partnerships foster a collaborative environment that encourages the exchange of ideas and the advancement of technology in bone substitute materials.
Conclusion
Frank Baumgart's contributions to the field of biomedical engineering, particularly through his patented method for producing bone substitute materials, highlight his innovative spirit and commitment to improving healthcare solutions. His work continues to influence the development of materials that support the healing and regeneration of bone tissue.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile